Síndrome de la vena cava superior de etiología maligna

1. Armstrong BA, Perez CA, Simpson JR, Hederman MA. Role of irradiation in the management of superior vena cava syndrome.Int J Radiat Oncol Biol Phys 1987;13:531-9.
2. Abner A. Approach to the patient who presents with superior vena cava obstruction. Chest 1993;103:Suppl 4:394S-397S.
3. Ostler PJ, Clarke DP, Watkinson AF, Gaze MN. Superior vena cava obstruction: a modern management strategy. Clin Oncol (R Coll Radiol) 1997;9:83-9.
4. Yellin A, Rosen A, Reichert N, Lieberman Y. Superior vena cava syndrome: the myth — the facts. Am Rev Respir Dis 1990;141:1114-8.
5. Schraufnagel DE, Hill R, Leech JA, Pare JA. Superior vena caval obstruction: is it a medical emergency? Am J Med 1981; 70:1169-74.
6. Kim HJ, Kim HS, Chung SH. CT diagnosis of superior vena cava syndrome: importance of collateral vessels. AJR Am J Roentgenol 1993;161:539-42.
7. Trigaux JP, Van Beers B. Thoracic collateral venous channels: normal and pathologic CT findings. J Comput Assist Tomogr 1990;14:769-73.
8. Gonzales-Fajardo JA, Garcia-Yuste M, Florez S, Ramos G, Alvarez T, Coca JM. Hemodynamic and cerebral repercussions arising from surgical interruption of the superior vena cava: experimental model. J Thorac Cardiovasc Surg 1994;107:1044-9.
9. Mineo TC, Ambrogi V, Nofroni I, Pistoléese C. Mediastinoscopy in superior vena cava obstruction: analysis of 80 consecutive patients. Ann Thorac Surg 1999;68:223-6.
10. Kishi K, Sonomura T, Mitsuzane K, et al. Self-expandable metallic stent therapy for superior vena cava syndrome: clinical observations. Radiology 1993;189:531-5.
11. Ahmann FR. A reassessment of the clinical implications of the superior vena caval syndrome. J Clin Oncol 1984;2:961-9.
12. Parish JM, Marschke RF Jr, Dines DE, Lee RE. Etiologic considerations in superior vena cava syndrome. Mayo Clin Proc 1981;56:407-13.
13. Chen JC, Bongard F, Klein SR. A comtemporary perspective on superior vena cava syndrome. Am J Surg 1990;160:207-11.
14. Rice TW, Rodriguez RM, Light RW. The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine (Baltimore) 2006;85:37-42.
15. Rice TW, Rodriguez RM, Barnette R, Light RW. Prevalence and characteristics of pleural effusions in superior vena cava syndrome. Respirology 2006;11:299-305.
16. Nicholson AA, Ettles DF, Arnold A, Greenstone M, Dyet JF. Treatment of malignant superior vena cava obstruction: metal stents or radiation therapy. J Vasc Interv Radiol 1997;8:781-8.
17. Detterbeck FC, Parsons AM. Thymic tumors. Ann Thorac Surg 2004;77:1860-9.
18. Urruticoechea A, Mesia R, Domínguez J, et al. Treatment of malignant superior vena cava syndrome by endovascular stent insertion: experience on 52 patients with lung cancer. Lung Cancer 2004;43:209-14.
19. Schwartz EE, Goodman LR, HaskinME. Role of CT scanning in the superior vena cava syndrome. Am J Clin Oncol 1986;9:71-8.
20. Stanford W, Jolles H, Ell S, Chiu LC. Superior vena cava obstruction: a venographic classification. AJR Am J Roentgenol 1987;148:259-62.
21. Khimji T, Zeiss J. MRI versus CT and US in the evaluation of a patient presenting with superior vena cava syndrome: case report. Clin Imaging 1992;16:269-71.
22. Dosios T, Theakos N, Chatziantoniou C. Cervical mediastinoscopy and anterior mediastinoscopy in superior vena cava obstruction. Chest 2005;128:1551-6.
23. Porte H, Metois D, Finzi L, et al. Superior vena cava syndrome of malignant origin: which surgical procedure for which diagnosis? Eur J Cardiothorac Surg 2000;17:384-8.
24. Marcy PY, Magne N, Bentolila F, Drouillard J, Bruneton JN, Descamps B. Superior vena cava obstruction: is stenting necessary? Support Care Cancer 2001;9:103-7.
25. Greillier L, Barlesi F, Doddoli C, et al. Vascular stenting for palliation of superior vena cava obstruction in non-small-cell lung cancer patients: a future ‘standard’ procedure? Respiration 2004;71:178-83.
26. Tanigawa N, Sawada S, Mishima K, et al. Clinical outcome of stenting in